Abstract
ABSTRACT: Subfraction 2R of fraction 9 from a peptic-tryptic-pancreatic digest of wheat gliadin is known to be toxic in vivo to celiac patients. We have found that fractions 9 and 2R inhibit the in vitro development of fetal rat intestine and the increase of enterocyte height occurring in organ culture of atrophic celiac mucosa (0.1–0.5 mg/ml medium). Other peptide fractions of the gliadin digest are devoid of such in vitro effects. Subfraction 2R, after incubation with morphologically normal small intestinal mucosa of celiacs in remission and ultrafiltration, was still very active in both culture systems at low concentration (0.1 mg/ml); on the contrary, subfraction 2R was inactivated after incubation with normal mucosa. These results are compatible with the hypothesis that there is a mucosal defect in handling gliadin peptides in celiac disease, and suggest that there is either a primary (or secondary) enzyme deficiency or some other mechanism operating in the intestinal mucosa of celiac patients in remission.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cornell, H., Auricchio, R., Ritis, G. et al. Intestinal Mucosa of Celiacs in Remission Is Unable To Abolish Toxicity of Gliadin Peptides on in Vitro Developing Fetal Rat Intestine And Cultured Atrophic Celiac Mucosa. Pediatr Res 24, 233–237 (1988). https://doi.org/10.1203/00006450-198808000-00019
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198808000-00019
This article is cited by
-
The multiple roles of sucrase-isomaltase in the intestinal physiology
Molecular and Cellular Pediatrics (2016)
-
Coeliac disease: A review of the causative agents and their possible mechanisms of action
Amino Acids (1996)
-
In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease
Journal of Protein Chemistry (1995)